Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,066 | -1,416 | -699 | -3,313 | -3,436 |
| Depreciation Amortization | 83 | 54 | 26 | 117 | 91 |
| Accounts receivable | -5 | 7 | 0 | 43 | 48 |
| Other Working Capital | 389 | 333 | 267 | 117 | 389 |
| Other Operating Activity | -468 | -414 | -238 | -643 | 116 |
| Operating Cash Flow | $-2,067 | $-1,437 | $-644 | $-3,679 | $-2,792 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -31 | -25 | -3 | -39 | -35 |
| Other Investing Activity | -31 | -25 | -3 | -39 | -35 |
| Investing Cash Flow | $-31 | $-25 | $-3 | $-39 | $-35 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,153 | 114 | 114 | 3,517 | 2,017 |
| Other Financing Activity | -358 | -89 | -46 | -738 | -345 |
| Financing Cash Flow | $795 | $24 | $68 | $2,780 | $1,673 |
| Exchange Rate Effect | 23 | 28 | 1 | -36 | 8 |
| Beginning Cash Position | 2,474 | 2,474 | 2,474 | 3,448 | 3,448 |
| End Cash Position | 1,194 | 1,064 | 1,895 | 2,474 | 2,301 |
| Net Cash Flow | $-1,280 | $-1,410 | $-578 | $-974 | $-1,147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,067 | -1,437 | -644 | -3,679 | -2,792 |
| Free Cash Flow | -2,067 | -1,437 | -644 | -3,679 | -2,792 |